Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
376.04
+4.54 (1.22%)
At close: Jul 24, 2026, 4:00 PM EDT
375.65
-0.39 (-0.10%)
After-hours: Jul 24, 2026, 7:53 PM EDT
Amgen Market Cap
Amgen has a market cap or net worth of $202.95 billion as of July 24, 2026. Its market cap has increased by 22.06% in one year.
Market Cap
202.95B
Enterprise Value
248.24B
1-Year Change
22.06%
Ranking
Category
Stock Price
$376.04
ChartMarket Cap Chart
Since December 1, 1998, Amgen's market cap has increased from $19.50B to $202.95B, an increase of 940.63%. That is a compound annual growth rate of 8.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 202.95B | 15.15% |
| Dec 31, 2025 | 176.25B | 25.80% |
| Dec 31, 2024 | 140.10B | -9.11% |
| Dec 29, 2023 | 154.14B | 9.99% |
| Dec 30, 2022 | 140.14B | 10.59% |
| Dec 31, 2021 | 126.72B | -5.33% |
| Dec 31, 2020 | 133.85B | -6.55% |
| Dec 31, 2019 | 143.24B | 15.47% |
| Dec 31, 2018 | 124.05B | -1.73% |
| Dec 29, 2017 | 126.24B | 16.06% |
| Dec 30, 2016 | 108.77B | -11.17% |
| Dec 31, 2015 | 122.45B | 1.06% |
| Dec 31, 2014 | 121.17B | 40.84% |
| Dec 31, 2013 | 86.03B | 30.06% |
| Dec 31, 2012 | 66.15B | 17.52% |
| Dec 30, 2011 | 56.28B | 8.51% |
| Dec 31, 2010 | 51.87B | -9.41% |
| Dec 31, 2009 | 57.26B | -6.42% |
| Dec 31, 2008 | 61.19B | 21.14% |
| Dec 31, 2007 | 50.51B | -36.61% |
| Dec 29, 2006 | 79.68B | -18.14% |
| Dec 30, 2005 | 97.34B | 19.46% |
| Dec 31, 2004 | 81.48B | 2.22% |
| Dec 31, 2003 | 79.71B | 28.11% |
| Dec 31, 2002 | 62.22B | 5.44% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Johnson & Johnson | 613.96B |
| AbbVie | 449.05B |
| Merck & Co. | 318.68B |
| Novartis AG | 292.88B |
| AstraZeneca | 263.57B |
| Novo Nordisk | 215.75B |
| Gilead Sciences | 158.98B |
| Pfizer | 141.63B |